In R/R TRBC1+ Patients
In R/R TRBC1+ Patients, AUTO4 CAR T-Cell Therapy Is Well Tolerated Lymphoma T-cell in the periphery
SG Tylor
Findings from the first-in-human AUTO4-TL1 trial (NCT03590574), which were presented at the 17th Annual International Conference on Malignant Lymphoma, showed ...
